Crossref
26-CVT-14356-ACC EVALUATION OF VUTRISIRAN IN ATTR AMYLOIDOSIS WITH CARDIOMYOPATHY
JACC · 2026-04 · 87 (13) · A1255
DOI: 10.1016/j.jacc.2026.02.3097 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Kristina Benbow.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Benbow, K. (2026). 26-CVT-14356-ACC EVALUATION OF VUTRISIRAN IN ATTR AMYLOIDOSIS WITH CARDIOMYOPATHY. JACC, 87(13), A1255. https://doi.org/10.1016/j.jacc.2026.02.3097
Vancouver
Benbow K. 26-CVT-14356-ACC EVALUATION OF VUTRISIRAN IN ATTR AMYLOIDOSIS WITH CARDIOMYOPATHY. JACC. 2026;87(13):A1255. doi:10.1016/j.jacc.2026.02.3097
BibTeX
@article{Benbow2026,
author = {Benbow, Kristina},
title = {26-CVT-14356-ACC EVALUATION OF VUTRISIRAN IN ATTR AMYLOIDOSIS WITH CARDIOMYOPATHY},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A1255},
doi = {10.1016/j.jacc.2026.02.3097}
}
EUVIMED